Chloé Takahashi

How to Design of Artificial Intelligence

Adequate Operative Treatment for Liver Cirrhosis (ADOPT-LC) Score

MobileHealth App 2015

Smartphones are so common now that most people have come

realize they are useful for more than a game of Candy Crush.

One study even predicted that in 2015,

more than 500 million smartphone users worldwide would be using health related apps.

But patients are not the only ones who find mobile applications useful.

Medical professionals around the world are already widely using a variety of apps to assist

with diagnoses, patient tracking, pharmaceutical interaction data, and much more.

Client: CureApp Inc.

My role: UI & UX Design

Using the Japanese nationwide database with more than 10 million patients,

I got the opportunity to work with one of to develop a model for

predicting in-hospital mortality of patients with surgical procedures

(excluding liver resection or transplantation).

This scoring system with simple parameters (patient age, Child-Pugh classification (A-C),

Charlson Comorbidity Index, and estimated duration of anesthesia) was

shown to provide higher predictive performance compared to Child-Pugh score (5-15 points) alone.

By the use of this scoring system,

this application software provides predicted in-hospital mortality calculated based on the 4 parameters you enter.

The inportance of Wireframe

Before beginning any design, I will often wireframe the overall information architecture of the product,

ensuring that the team identify potential interaction points before moving to more detailed work.

This process goes hand in hand with team's interaction design and prototyping.

Forbes Japan

Recently the company and the product has appeared in Forbes Magazine Japan.

I hope this app will help a lot of doctors and patients

as same as some doctor saved my life when I was young.

This application software is developed or powered by

Department of Gastroenterology (Liver Study Group),

Department of Clinical Epidemiology and Health Economics

at The University of Tokyo, and CureApp, Inc.